Stay updated on Dapagliflozin Effects on Heart in Diabetes Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.

Latest updates to the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe DAPACARD record is displayed with its study design, eligibility criteria, locations, outcome measures, investigators, and study documents. It describes a completed Phase IV study of dapagliflozin versus placebo in people with type 2 diabetes.SummaryDifference48%

- Check19 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check26 days agoChange DetectedA sitewide banner announces updates to NIH websites and says the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check33 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page now displays a 403 Forbidden error page with a minimal HTML header and a Home link. This indicates access is blocked rather than showing the study record content.SummaryDifference18%

Stay in the know with updates to Dapagliflozin Effects on Heart in Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Effects on Heart in Diabetes Clinical Trial page.